Prescribing patterns and safety of biologics in immune-mediated rheumatic diseases: Karnataka biologics cohort study group experience by Vineeta Shobha, Vijay Rao, Anu Mohan Desai, Ramesh Jois, Chandrashekara Srikantiah, B G Dharmanand, Sharath Kumar, Pradeep Kumar, Chethana Dharmapalaiah, K M Mahendranath, Shiva Prasad, Manisha Daware, Yogesh Singh, Uma Karjigi

“…Pre-screening for latent tuberculosis (TB) is consistent across centres, and TB prophylaxis appears to be effective in preventing its reactivation.…”
Get full text

Multiple Abdominal Cocoons: An Unusual Presentation of Intestinal Obstruction and a Diagnostic Dilemma by Mohammad Zain Sohail, Shumaila Hasan, Benan Dala-Ali, Shahanoor Ali, M. A. Hashmi

“…We present the case of a 42-year-old gentleman with a history of hepatitis C, tuberculosis, and previous abdominal surgery, who presented with subacute intestinal obstruction. …”
Get full text

Impact of media coverage on the transmission dynamics of TB with vaccines and treatment. by Kumneger Tadesse Mulugeta, Mohammed Yiha Dawed, Shewafera Wondimagegnhu Teklu

“…Tuberculosis (TB) is one of the deadly infectious diseases affecting millions of individuals throughout the world. …”
Get full text

Synthesis of Substituted Thioureas and Their Sulfur Heterocyclic Systems of p-Amino Salicylic Acid as Antimycobacterial Agents by Mohammed Saleh I. T. Makki, Reda M. Abdel-Rahman, Hassan M. Faidallah, Khalid Ali Khan

“…The in vitro antitubercular activity of synthesized compounds against M. tuberculosis strain H37Rv showed moderate-to-good activity.…”
Get full text

Pulmonary Rehabilitation of a Patient after Lobectomy Secondary to Pulmonary Aspergilloma: A Case Report by Adriana Maria Dsouza, Abeeshna Ashok

“…There is a high prevalence of aspergilloma in patients who have previously been affected by pulmonary tuberculosis. The present case report was aimed to describe the radiological features and functional activity limitations of a patient diagnosed with aspergilloma who underwent lobectomy of the superior lobe, middle lobe and superior segment of the lower lobe. …”
Get full text

Identification of pathogenic bacteria by biosensors in water and wastewater by Sakineh Hargolzadeh, Soheila Kashanian, Maryam Nazari

“…Pathogenic microorganisms, such as Escherichia coli, Salmonella, Pseudomonas aeruginosa, Mycobacterium tuberculosis, Staphylococcus aureus, Klebsiella pneumoniae, legionella, Shigella and etc. can contaminate drinking water and lead to disease and even death. …”
Get full text

The silent menace: Worm bezoar causing acute intestinal obstruction by Shiva Shiva, Sahil Kumar, Pankaj Singh, Sanjeev Kumar, Suresh Kumar

“…In contrast to developed nations, where the usual causes of obstruction are adhesions, strictures, and metabolic derangements, infective etiologies, like tuberculosis and parasitic infestations, are more common in developing countries. …”
Get full text

Diagnosis dan Tatalaksana Penyakit Paru Nontuberculous mycobacteria by Linda Ratna Juita, Fauzar Fauzar

“…Nontuberculous mycobacteria (NTM) juga dikenal dengan atypical mycobacteria atau mycobacteria other than tuberculosis merupakan organisme patogen oportunistik yang dapat menyebabkan penyakit paru progresif. …”
Get full text

Clinical Insights into Tubercular Tenosynovitis: A Series of Eight Compound Palmar Ganglion Cases by Esa Gokulakrishnan, Prem K Kothimbakkam, Bharath Vadivelkumar, Vijayashankar Murugesan

“…Chronic flexor tenosynovitis of the wrist is often associated with tuberculosis in developing countries as opposed to rheumatoid arthritis in developed countries. …”
Get full text

Chylopericardium due to Subclavian Vein Thrombosis in the Setting of Protein S Deficiency by Ian Jackson, Yaman Alali, Abedel Rahman Anani, Ali Nayfeh, Arindam Sharma, Abhishek Thandra, Amjad Kabach

“…It can be idiopathic or secondary to trauma, cardiothoracic surgery, neoplasm, radiation, tuberculosis, lymphatic duct dysfunction, thrombosis, or other causes. …”
Get full text

La Vallée de l’Arve à l’épreuve de la santé environnementale : entre imaginaire thérapeutique et éco-anxiété by Alexandre Savioz

“…Historically, the Plateau d'Assy in the Arve Valley was a major healthcare destination, particularly specializing in the treatment of tuberculosis between the 1920s and 1970s. From the 19th century onwards, a collective imagination emerged around the myth of clean air of the mountains. …”
Get full text

Noninvasive Techniques for Management of Erythema Multiforme by Fabiana Martins, Debora Pallos, Jodkandlys Candeia, Rodrigo Zerbinati, Paulo Henrique Braz-Silva, Luana Campos

“…During the interview, he reported a medical history of ganglionic tuberculosis, type 2 herpes infection, and significant weight loss due to dysphagia. …”
Get full text

Mollicutes/HIV Coinfection and the Development of AIDS: Still Far from a Definitive Response by Caio Mauricio Mendes de Cordova, Caroline Galgowski, Leonardo Lange

“…Even today this point of view is quite polemic among infectious disease specialists and many aspects remain to be clarified, in contrast to what happens, for instance, with HIV/Mycobacterium tuberculosis coinfection. Dozens of papers have been published covering aspects of Mollicutes/HIV coinfection, but they add little to no information about the putative contribution of Mollicutes to the evolution of AIDS. …”
Get full text

Progress in voluntary medical male circumcision for HIV prevention supported by the US President’s Emergency Plan for AIDS Relief through 2017: longitudinal and recent cross-sectio... by Carlos Toledo, Melissa Habel, Stephanie M Davis, Jonas Z Hines, Jonathan M Grund, Renee Ridzon, Brittney Baack, Jonathan Davitte, Anne Thomas, Valerian Kiggundu, Naomi Bock, Paran Pordell, Caroline Cooney, Irum Zaidi

Get full text

«Green-Ligand» in Metallodrugs Design—Cu(II) Complex with Phytic Acid: Synthetic Approach, EPR-Spectroscopy, and Antimycobacterial Activity by Kseniya A. Koshenskova, Natalia V. Makarenko, Fedor M. Dolgushin, Dmitriy S. Yambulatov, Olga B. Bekker, Matvey V. Fedin, Sergei A. Dementev, Olesya A. Krumkacheva, Igor L. Eremenko, Irina A. Lutsenko

“…The biological activity of <b>1</b> in vitro against the non-pathogenic (model for <i>Mycobacterium tuberculosis</i>) strain of <i>Mycolicibacterium smegmatis</i> is comparable to the first-line drug for tuberculosis treatment, rifampicin.…”
Get full text

MsDpo4—a DinB Homolog from Mycobacterium smegmatis—Is an Error-Prone DNA Polymerase That Can Promote G:T and T:G Mismatches by Amit Sharma, Deepak T. Nair

“…However, unlike E. coli, it has been seen that expression of the homologs of dinB in Mycobacterium tuberculosis are not upregulated under conditions of stress. …”
Get full text

The Role of Psychology Towards Sustainable Development Goal 3: Good Health and Wellbeing in South Africa by Ntombophelo Sithole-Tetani

“…The third SDG, ‘Good Health and Wellbeing,’ aims to ensure healthy lives, promote well-being for all ages, and halt and reverse global illnesses such as HIV, tuberculosis, and the COVID-19 pandemic, etc. This paper used a narrative literature review to discuss the role of psychology in SDG3 in the South African Context. …”
Get full text

Rifampicin in Nontuberculous Mycobacterial Infections: Acute Kidney Injury with Hemoglobin Casts by Rishi Kora, Sergey V. Brodsky, Tibor Nadasdy, Dean Agra, Anjali A. Satoskar

“…Rifampicin is a key component of multidrug regimens not only for tuberculosis, but also nontuberculous mycobacterial infections (NTM) which are on the rise worldwide. …”
Get full text

Synthesis of trehalose-based chemical tools for the study of the mycobacterial membrane by Lesur, Emilie, Rollando, Paulin, Guianvarc’h, Dominique, Bourdreux, Yann

“…Corynebacteriales including the causative agent of many diseases such as tuberculosis are known to be extremely resistant against external stress as well as to antibiotic treatments which is believed to be related to the singular architecture of their mycomembrane. …”
Get full text

DESCRIPTION OF THE CAUSES OF MDR-TB AT IBNU SINA HOSPITAL GRESIK by Cucuk Rahmadi Purwanto, Marissa Widyamulya, Fanni Okviasanti

“…Introduction: The causes of Multidrug Resistance Tuberculosis (MDR-TB) are very diverse; MDR-TB treatment, which takes a long time of approximately 18-24 months, so it becomes a severe health problem because of its rapid and increasing transmission. …”
Get full text